Add like
Add dislike
Add to saved papers

In-situ assembling novel N-Ti 3 C 2 /BiOCl x Br 1-x composites with enhanced photocatalytic degradation and nitrogen reduction activity.

Herein, a collection of novel N-Ti3 C2 /BiOClx Br1-x composites are fabricated via a simple in-situ sonochemical process. Not only the preparation method for N-Ti3 C2 but also the photocatalytic system of N-Ti3 C2 /BiOClx Br1-x are firstly developed. Multiple characterizations jointly demonstrate the successful fabrication of the composites. Compared to that of BiOClx Br1-x , the maximum improvements of 1.16, 1.25 and 1.26 folds are severally confirmed for the photocatalytic degradation of levofloxacin, Rhodamine B, and methylene blue over N-Ti3 C2 /BiOClx Br1-x composites. In addition, through radicals trapping tests, the primary active species in photocatalytic degradation process are verified to be O2 - . Moreover, N-Ti3 C2 /BiOClx Br1-x composites also exhibit 1.18 and 1.14 times enhancements for NH3 production compared with that of BiOClx Br1-x with or without the presence of methanol, respectively. In addition, the maximum improvements of photo-current and photo-potential for BiOClx Br1-x are 1.29 and 1.86 folds with the introduction of N-Ti3 C2 , respectively. The enhanced photocatalytic activity of N-Ti3 C2 /BiOClx Br1-x composites is owing to the heightened light absorption, increased specific surface area, and accelerated separation of photoinduced carriers. Additionally, the stable photocatalytic properties of N-Ti3 C2 /BiOClx Br1-x are confirmed by three photocatalytic recycle tests on pollutant degradation and nitrogen reduction combined with X-ray diffraction patterns before and after three recycles. This study suggests that N-Ti3 C2 is an efficient ornamentation for boosting photocatalytic activity ofBiOClx Br1-x , which can also be expanded as a promising modifier for other semiconductors.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app